Skip to main content
Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · Real-Time Price · USD
9.45
+0.04 (0.43%)
At close: Dec 20, 2024, 4:00 PM
9.36
-0.09 (-0.95%)
After-hours: Dec 20, 2024, 6:29 PM EST

Poseida Therapeutics Revenue

Poseida Therapeutics had revenue of $71.75M in the quarter ending September 30, 2024, with 667.19% growth. This brings the company's revenue in the last twelve months to $150.86M, up 203.18% year-over-year. In the year 2023, Poseida Therapeutics had annual revenue of $64.70M, down -50.42%.

Revenue (ttm)
$150.86M
Revenue Growth
+203.18%
P/S Ratio
6.04
Revenue / Employee
$457,145
Employees
330
Market Cap
921.06M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202364.70M-65.79M-50.42%
Dec 31, 2022130.49M99.25M317.73%
Dec 31, 202131.24M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owens & Minor 10.66B
Pacira BioSciences 694.96M
The Pennant Group 652.30M
HealthStream 287.99M
Gyre Therapeutics 105.03M
Zymeworks 62.20M
CeriBell 60.04M
Revenue Rankings

PSTX News

More News